Vector competence and immune response of Aedes aegypti for Ebinur Lake virus, a newly classified mosquito-borne orthobunyavirus.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
07 2022
Historique:
received: 20 02 2022
accepted: 08 07 2022
revised: 28 07 2022
pubmed: 19 7 2022
medline: 2 8 2022
entrez: 18 7 2022
Statut: epublish

Résumé

The global impact of mosquito-borne diseases has increased significantly over recent decades. Ebinur Lake virus (EBIV), a newly classified orthobunyavirus, is reported to be highly pathogenic in adult mice. The evaluation of vector competence is essential for predicting the arbovirus transmission risk. Here, Aedes aegypti was applied to evaluate EBIV infection and dissemination in mosquitos. Our experiments indicated that Ae. aegypti had the possibility to spread EBIV (with a transmission rate of up to 11.8% at 14 days post-infection) through biting, with the highest viral dose in a single mosquito's saliva reaching 6.3 plaque-forming units. The highest infection, dissemination and ovary infection rates were 70%, 42.9%, and 29.4%, respectively. The high viral infection rates in Ae. aegypti ovaries imply the possibility of EBIV vertical transmission. Ae. aegypti was highly susceptible to intrathoracic infection and the saliva-positive rate reached 90% at 10 days post-infection. Transcriptomic analysis revealed Toll and Imd signaling pathways were implicated in the mosquito's defensive response to EBIV infection. Defensin C and chitinase 10 were continuously downregulated in mosquitoes infected via intrathoracic inoculation of EBIV. Comprehensive analysis of the vector competence of Ae. aegypti for EBIV in laboratory has indicated the potential risk of EBIV transmission through mosquitoes. Moreover, our findings support a complex interplay between EBIV and the immune system of mosquito, which could affect its vector competence.

Identifiants

pubmed: 35849620
doi: 10.1371/journal.pntd.0010642
pii: PNTD-D-22-00238
pmc: PMC9333442
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010642

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Rev Med Virol. 2018 Jan;28(1):
pubmed: 29210509
Vector Borne Zoonotic Dis. 2020 Feb;20(2):71-81
pubmed: 31556813
J Med Entomol. 2016 Nov;53(6):1415-1421
pubmed: 27605372
Cell Host Microbe. 2010 Jun 25;7(6):488-99
pubmed: 20542252
Virol J. 2021 Oct 12;18(1):204
pubmed: 34641884
J Med Entomol. 1993 Mar;30(2):326-31
pubmed: 8459409
J Med Entomol. 1991 May;28(3):378-86
pubmed: 1875364
Curr Opin Insect Sci. 2017 Aug;22:1-6
pubmed: 28805630
Vector Borne Zoonotic Dis. 2021 Oct;21(10):731-746
pubmed: 34424778
Front Microbiol. 2020 Jan 30;10:3111
pubmed: 32082268
J Med Entomol. 2015 Jul;52(4):672-82
pubmed: 26335474
Trends Parasitol. 2018 Apr;34(4):310-321
pubmed: 29305089
J Med Entomol. 2014 Nov 1;51(6):1248-53
pubmed: 26309314
Proc Natl Acad Sci U S A. 1952 Aug;38(8):747-52
pubmed: 16589172
Nat Rev Microbiol. 2014 Oct;12(10):673-85
pubmed: 25198140
Microbes Infect. 2002 Mar;4(3):341-50
pubmed: 11909745
Annu Rev Biochem. 2010;79:803-33
pubmed: 20196649
Insects. 2019 Feb 01;10(2):
pubmed: 30717086
Virus Res. 2012 Dec;170(1-2):25-33
pubmed: 22877689
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11344-9
pubmed: 15277679
PLoS Pathog. 2007 Dec;3(12):e201
pubmed: 18069894
Trends Parasitol. 2019 Dec;35(12):1009-1017
pubmed: 31669148
Viruses. 2015 Jul 08;7(7):3741-67
pubmed: 26184281
J Microbiol Immunol Infect. 2020 Dec;53(6):925-935
pubmed: 31630962
Parasit Vectors. 2021 Oct 30;14(1):561
pubmed: 34717742
Front Microbiol. 2021 Feb 01;11:625661
pubmed: 33597934
Proc Natl Acad Sci U S A. 2021 Oct 19;118(42):
pubmed: 34620704
Immunity. 2009 Apr 17;30(4):588-98
pubmed: 19362021
Nature. 2017 May 25;545(7655):482-486
pubmed: 28514450
Virol Sin. 2018 Feb;33(1):5-20
pubmed: 29532388
PLoS Negl Trop Dis. 2020 May 18;14(5):e0007754
pubmed: 32421713
Virol J. 2011 Mar 24;8:135
pubmed: 21435229
Am J Trop Med Hyg. 1984 Sep;33(5):953-60
pubmed: 6541436
Front Vet Sci. 2018 Apr 12;5:69
pubmed: 29707545
Nat Commun. 2020 Jan 14;11(1):260
pubmed: 31937766
Parasit Vectors. 2019 Jul 31;12(1):384
pubmed: 31366369
J Virol Methods. 2016 Oct;236:93-97
pubmed: 27444120
Immunity. 2012 Apr 20;36(4):658-67
pubmed: 22464169
Front Public Health. 2019 Jun 12;7:148
pubmed: 31249824
J Am Mosq Control Assoc. 1991 Jun;7(2):170-5
pubmed: 1895074
PLoS Negl Trop Dis. 2018 Nov 19;12(11):e0006949
pubmed: 30452443
Med Vet Entomol. 2015 Sep;29(3):338-43
pubmed: 25991544
J Neuroinflammation. 2017 Mar 24;14(1):62
pubmed: 28340587
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Aug;35(8):939-42
pubmed: 25376687
Nat Microbiol. 2020 Feb;5(2):239-247
pubmed: 31819213
Am J Trop Med Hyg. 1984 Jan;33(1):176-81
pubmed: 6696176
Genome Announc. 2014 Jun 19;2(3):
pubmed: 24948753
Nucleic Acids Res. 2020 Jul 27;48(13):7371-7384
pubmed: 32556261
Nat Commun. 2021 May 4;12(1):2522
pubmed: 33947846
Curr Opin Virol. 2019 Feb;34:104-109
pubmed: 30743191
Immunity. 2014 Jan 16;40(1):51-65
pubmed: 24374193
Cells. 2019 May 17;8(5):
pubmed: 31108880

Auteurs

Cihan Yang (C)

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
University of Chinese Academy of Sciences, Beijing, China.

Fei Wang (F)

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.

Doudou Huang (D)

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.

Haixia Ma (H)

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.

Lu Zhao (L)

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.

Guilin Zhang (G)

Xinjiang Heribase Biotechnology CO., LTD., Urumqi, Xinjiang, China.

Hailong Li (H)

Center for Disease Control and Prevention of Xinjiang Military Command Area, Urumqi, Xinjiang, China.

Qian Han (Q)

One Health Institute, Hainan University, Haikou, Hainan, China.

Dennis Bente (D)

Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.

Ferdinand Villanueva Salazar (FV)

Department of Medical Entomology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines.

Zhiming Yuan (Z)

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
University of Chinese Academy of Sciences, Beijing, China.

Han Xia (H)

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
University of Chinese Academy of Sciences, Beijing, China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH